Evogene: Evogene and Google Cloud Partner to Develop AI Foundation Model for Drug Discovery

What You Should Know: - Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and development, today announced a collaboration with Google Cloud to develop a cutting-edge foundation model for generative small molecule de novo design, propelling Evogene's ChemPass AI tech-engine to new levels of innovation. - ChemPass AI is ... Read More